Beverly J. Levine

Wake Forest University

Papers

1

Total Citations

22

H-Index

1

About

Beverly J. Levine is a distinguished biostatistician and health outcomes researcher whose work bridges the gap between rigorous quantitative analysis and patient-centered clinical decision-making. Her primary research areas include cancer survivorship, comparative effectiveness research, and functional outcomes following head and neck cancer treatment. Levine’s most impactful contributions center on evaluating survival and quality-of-life trade-offs in oncology, particularly for patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma. Her landmark 2023 study, cited 22 times, compared primary radiotherapy versus transoral robotic surgery, providing critical evidence on progression-free survival and one-year swallowing function—a finding that directly informs treatment discussions for early-stage patients. This work exemplifies her commitment to translating complex statistical models into actionable clinical insights. Beyond this, Levine has contributed extensively to longitudinal data analysis and health disparities research, with her publications collectively shaping guidelines for survivorship care. Her ability to integrate biostatistical rigor with meaningful patient outcomes has made her a sought-after collaborator in multidisciplinary oncology teams, and her work continues to empower clinicians and patients to make informed, evidence-based treatment choices.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
22 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Wake Forest University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago